Results 1 to 10 of about 516 (124)

POLYMYALGIA RHEUMATICA [PDF]

open access: yesНаучно-практическая ревматология, 2018
The lecture presents an update on the epidemiology, pathogenesis, clinical manifestations, diagnosis, differential diagnosis, and treatment stages of polymyalgia rheumatica, a chronic inflammatory disease of unknown etiology, which affects older people.--
A. M. Satybaldyev   +3 more
doaj   +3 more sources

Pathogenesis of polymyalgia rheumatica

open access: yesReumatismo, 2018
Polymyalgia rheumatica (PMR) is a chronic, inflammatory disorder of unknown cause, almost exclusively occurring in people aged over 50 and often associated with giant cell arteritis.
G. Guggino   +4 more
doaj   +5 more sources

Comorbidity in polymyalgia rheumatica

open access: yesReumatismo, 2018
Polymyalgia rheumatica (PMR) is the commonest inflammatory rheumatic disease affecting older people. The current mainstay of treatment is long-term oral glucocorticoid therapy. Management of these patients in clinical practice is often complicated by the
C. Chatzigeorgiou, S.L. Mackie
doaj   +5 more sources

Imaging in polymyalgia rheumatica

open access: yesReumatismo, 2018
Polymyalgia rheumatica (PMR) is a chronic, inflammatory disorder of unknown cause clinically characterized by pain and prolonged morning stiffness affecting the shoulders and often the pelvic girdle and neck.
N. Possemato, C. Salvarani, N. Pipitone
doaj   +5 more sources

Polymyalgia rheumatica

open access: yesDeutsches Ärzteblatt international, 2022
Polymyalgia rheumatica (PMR) is among the most common inflammatory rheumatic diseases in older adults. Presumed risk factors include female sex, previous infections, and genetic factors. No epidemiological data on PMR in Germany have been available until now.This review is based on publications retrieved by a selective literature search in PubMed ...
Miriam Giovanna, Colombo   +5 more
openaire   +2 more sources

Frequency of Immune Checkpoint Inhibitor-Induced Vasculitides: An Observational Study Using Data From the Japanese Adverse Drug Event Report Database

open access: yesFrontiers in Pharmacology, 2022
Information on immune checkpoint inhibitor-induced vasculitides is limited, and predictors for this condition have not been identified. Therefore, we have examined the frequency of immune checkpoint inhibitor-induced vasculitides by analyzing the data ...
Koki Kato   +6 more
doaj   +1 more source

Polymyalgia rheumatica presenting as sternoclavicular arthritis: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Polymyalgia rheumatica and giant cell arteritis are systemic inflammatory conditions of the elderly. Polymyalgia rheumatica classically presents as a bilateral proximal muscle pain and stiffness syndrome.
Liyana Arachchige Dona Thulini Madubashini   +2 more
doaj   +1 more source

Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis

open access: yesFrontiers in Medicine, 2023
Rheumatoid arthritis is a chronic autoimmune disease that mainly affects the facet joints. Elderly-onset rheumatoid arthritis appears to exhibit symptoms similar to those of polymyalgia rheumatica, characterized by morning stiffness and pain in the ...
Jinzhi Wu   +4 more
doaj   +1 more source

Polymyalgia rheumatica [PDF]

open access: yesDer Internist, 2008
Polymyalgia rheumatica (PMR) is a common chronic inflammatory rheumatic disease with unknown aetiology, affecting predominately people of middle age and older. Besides clinical symptoms and diagnostics, imaging techniques including sonography and magnetic resonance imaging may provide evidence of typical inflammatory lesions with bilateral bursitis ...
C, Duftner, C, Dejaco, M, Schirmer
openaire   +4 more sources

Acute cholangitis following mRNA COVID-19 vaccine booster in a patient receiving an anti-amyloid antibody for Alzheimer’s disease: A case report

open access: yesSAGE Open Medical Case Reports, 2023
A 77-year-old woman had 2 weeks of fever and flu-like symptoms starting several hours after receiving an mRNA booster for SARS-CoV-2 and the influenza vaccine, in separate shots. Laboratory tests showed cholangitis.
Linda L Restifo, Robert P Erickson
doaj   +1 more source

Home - About - Disclaimer - Privacy